ASH 2021 Conference Coverage on VuMedi
Playback speed
10 seconds
ASH 2021: Genomic and Immune Signatures Predict Sustained MRD Negativity in NDMM Patients Treated with D-KRd
By
ASH 2021 Conference Coverage on VuMedi
FEATURING
Eileen Boyle
By
ASH 2021 Conference Coverage on VuMedi
FEATURING
Eileen Boyle
166 views
December 16, 2021
Comments 0
Login to view comments.
Click here to Login
Myeloma